Effect of Modified Complete Decongestive Therapy on Lower Limbs Fibrosis Post Cellulitis

Launched by CAIRO UNIVERSITY · Dec 13, 2022

Keywords

ClinConnect Summary

This clinical trial is investigating a treatment approach for patients who have lower limb lymphedema, which is swelling caused by a buildup of lymph fluid, often following cellulitis, a skin infection. The study will look at how a combination of kinesio tape—a flexible tape used to support muscles—and complete decongestive therapy can help improve limb size, skin condition, movement, and overall quality of life. The goal is to find effective ways to manage symptoms like pain and heaviness in the legs.

To participate in this trial, you would need to be between 45 and 55 years old, have mild lymphedema (stage 2), and be in stable health. It's important that you have been free from cellulitis for at least two weeks and do not have certain health issues like severe heart problems or infections. If you join the trial, you can expect to receive specialized treatments and care to help improve your condition, and your progress will be monitored throughout the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient will be according the following criteria:-
• • 1. Males and females with Lower limb lymphedema Stage 2.
• • 2. Age will range from45 to 55years old.
• • 3. BMI \<40 (kg/m2).
• • 4. All patients will be clinically and medically stable when attending the study.
• • 5. Patients free from any acute conditions.
• • 6. Post cellulitis for at least 2 weeks.
• Exclusion Criteria:
• • 1. Unstable cardiovascular problems.
• • 2. Altered mental status or poor cognition.
• • 3. Lower limb ischemia (ABI ≤0.8).
• • 4. Lower limb lymphedema stage 3\&4.
• • 5. Acute deep venous thrombosis.
• • 6. Any acute infection.
• • 7. Patients with orthopedic or neurological limitations to exercise.
• • 8. Any lower limb acute ulcer or arterial wounds.